WEEKLY CISPLATIN INDUCTION CHEMOTHERAPY IN THE TREATMENT OF RECURRENT CERVICAL-CARCINOMA

被引：36

作者：

LELE, SB

PIVER, MS

机构：

来源：

GYNECOLOGIC ONCOLOGY | 1989年 / 33卷 / 01期

关键词：

D O I：

10.1016/0090-8258(89)90594-5

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：6 / 8

页数：3

共 11 条

[1] PHASE-II RANDOMIZED TRIAL OF CISPLATIN CHEMOTHERAPY REGIMENS IN THE TREATMENT OF RECURRENT OR METASTATIC SQUAMOUS-CELL CANCER OF THE CERVIX - A SOUTHWEST-ONCOLOGY-GROUP STUDY [J].

ALBERTS, DS ;

KRONMAL, R ;

BAKER, LH ;

STOCKNOVACK, DL ;

SURWIT, EA ;

BOUTSELIS, JG ;

HANNIGAN, EV .

JOURNAL OF CLINICAL ONCOLOGY, 1987, 5 (11) :1791-1795

[2] RANDOMIZED TRIAL OF 3 CISPLATIN DOSE SCHEDULES IN SQUAMOUS-CELL CARCINOMA OF THE CERVIX - A GYNECOLOGIC ONCOLOGY GROUP-STUDY [J].

BONOMI, P ;

BLESSING, JA ;

STEHMAN, FB ;

DISAIA, PJ ;

WALTON, L ;

MAJOR, FJ .

JOURNAL OF CLINICAL ONCOLOGY, 1985, 3 (08) :1079-1085

[3]

LELE SB, 1983, GYNECOL ONCOL, V16, P15, DOI 10.1016/0090-8258(83)90003-3

[4] WEEKLY CIS-DIAMMINEDICHLOROPLATINUM-II AS INDUCTION CHEMOTHERAPY IN RECURRENT CARCINOMA OF THE CERVIX [J].

PIVER, MS ;

BARLOW, JJ ;

LELE, SB ;

MANICCIA, M .

GYNECOLOGIC ONCOLOGY, 1984, 18 (03) :313-319

[5] 1.5-5 YEARS OF UNINTERRUPTED CIS-DIAMMINEDICHLOROPLATINUM-II CHEMOTHERAPY FOR METASTATIC CERVICAL-CANCER [J].

PIVER, MS ;

LELE, SB ;

PATSNER, B ;

MCPHEE, ME .

GYNECOLOGIC ONCOLOGY, 1987, 27 (01) :24-33

[6] THE IMPACT OF AGGRESSIVE DEBULKING SURGERY AND CISPLATIN-BASED CHEMOTHERAPY ON PROGRESSION-FREE SURVIVAL IN STAGE-III AND STAGE-IV OVARIAN-CARCINOMA [J].

PIVER, MS ;

LELE, SB ;

MARCHETTI, DL ;

BAKER, TR ;

TSUKADA, Y ;

EMRICH, LJ .

JOURNAL OF CLINICAL ONCOLOGY, 1988, 6 (06) :983-989

[7]

PIVER MS, 1980, CANCER TREAT REP, V64, P1379

[8] ADRIAMYCIN ALONE OR IN COMBINATION IN 100 PATIENTS WITH CARCINOMA OF CERVIX OR VAGINA [J].

PIVER, MS ;

BARLOW, JJ ;

XYNOS, FP .

AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1978, 131 (03) :311-313

[9]

PIVER MS, 1979, CANCER TREAT REP, V63, P265

[10] CIS-DIAMMINEDICHLOROPLATINUM (II) - 2ND LINE INDUCTION CHEMOTHERAPY IN ADVANCED OVARIAN ADENOCARCINOMA [J].

PIVER, MS ;

BARLOW, JJ ;

LELE, SB ;

MALFETANO, JH ;

MCPHEE, ME .

JOURNAL OF SURGICAL ONCOLOGY, 1983, 24 (04) :329-331

← 1 2 →